130 related articles for article (PubMed ID: 9016843)
21. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats.
Wiegmann K; Muthyala S; Kim DH; Arnason BG; Chelmicka-Schorr E
J Neuroimmunol; 1995 Feb; 56(2):201-6. PubMed ID: 7860715
[TBL] [Abstract][Full Text] [Related]
22. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
[TBL] [Abstract][Full Text] [Related]
23. Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis.
White SR; Vyas D; Bieger D
Neuroscience; 1985 Nov; 16(3):701-9. PubMed ID: 3912676
[TBL] [Abstract][Full Text] [Related]
24. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis.
Daniel PM; Lam DK; Pratt OE
J Neurol Sci; 1981; 52(2-3):211-9. PubMed ID: 6796652
[TBL] [Abstract][Full Text] [Related]
25. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
Rousseau V; Denizot B; Le Jeune JJ; Jallet P
Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
O'Neill JK; Baker D; Turk JL
J Neuroimmunol; 1992 Dec; 41(2):177-87. PubMed ID: 1469077
[TBL] [Abstract][Full Text] [Related]
27. Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis.
Mohamed A; Afridi DM; Garani O; Tucci M
Biomed Sci Instrum; 2005; 41():388-93. PubMed ID: 15850137
[TBL] [Abstract][Full Text] [Related]
28. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis.
Calza L; Fernandez M; Giuliani A; Aloe L; Giardino L
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3258-63. PubMed ID: 11867745
[TBL] [Abstract][Full Text] [Related]
29. Influence of gangliosides on experimental allergic neuritis.
Wiethölter H; Schabet M; Stevens A; Melms A; Sommer N; Weller M
J Neuroimmunol; 1992 Jun; 38(3):221-8. PubMed ID: 1601979
[TBL] [Abstract][Full Text] [Related]
30. The pathophysiology of acute experimental allergic encephalomyelitis induced by whole spinal cord in the Lewis rat.
Pender MP
J Neurol Sci; 1988 Apr; 84(2-3):209-22. PubMed ID: 3259977
[TBL] [Abstract][Full Text] [Related]
31. Localized 1H NMR spectroscopy of rat spinal cord in vivo.
Zelaya FO; Chalk JB; Mullins P; Brereton IM; Doddrell DM
Magn Reson Med; 1996 Apr; 35(4):443-8. PubMed ID: 8992192
[TBL] [Abstract][Full Text] [Related]
32. Changes in amino acid contents in the spinal cord and brainstem of rats with experimental autoimmune encephalomyelitis.
Honegger CG; Krenger W; Langemann H
J Neurochem; 1989 Aug; 53(2):423-7. PubMed ID: 2787389
[TBL] [Abstract][Full Text] [Related]
33. Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats.
Paterson PY; Harvey JM; Webster LT
J Immunol; 1977 Jun; 118(6):2151-4. PubMed ID: 301156
[TBL] [Abstract][Full Text] [Related]
34. Studies on the encephalitogenic effects of purified preparations of human and bovine oligodendrocytes.
Raine CS; Wiśniewski HM; Iqbal K; Grundkeiqbal I; Norton WT
Brain Res; 1977 Jan; 120(2):269-86. PubMed ID: 64280
[TBL] [Abstract][Full Text] [Related]
35. Gangliosides offer partial protection in experimental allergic neuritis.
Ledeen RW; Oderfeld-Nowak B; Brosnan CF; Cervone A
Ann Neurol; 1990; 27 Suppl():S69-74. PubMed ID: 2363571
[TBL] [Abstract][Full Text] [Related]
36. Preventive and therapeutic effects of cyclosporin and valine2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
Feurer C; Chow LH; Borel JF
Immunology; 1988 Feb; 63(2):219-23. PubMed ID: 3258272
[TBL] [Abstract][Full Text] [Related]
37. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
Stohl W; Gonatas NK
J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
[TBL] [Abstract][Full Text] [Related]
38. Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats.
Bø L; Olsson T; Nyland H; Krüger PG; Taule A; Mørk S
J Neurol Sci; 1991 Oct; 105(2):135-42. PubMed ID: 1757789
[TBL] [Abstract][Full Text] [Related]
39. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE.
Matsumoto Y; Fujiwara M
J Neurol Sci; 1987 Jan; 77(1):35-47. PubMed ID: 2433404
[TBL] [Abstract][Full Text] [Related]
40. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
